Cogent Biosciences
COGT
#5783
Rank
C$1.24 B
Marketcap
$11.25
Share price
0.51%
Change (1 day)
47.86%
Change (1 year)

Cogent Biosciences (COGT) - Cash on Hand

Cash on Hand as of September 2024 : C$0.48 Billion

According to Cogent Biosciences's latest financial reports the company has C$0.48 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cogent Biosciences - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$0.35 B0.17%
2022-12-31C$0.35 B25.66%
2021-12-31C$0.27 B-9.34%
2020-12-31C$0.30 B531.8%
2019-12-31C$48.87 M-54.35%
2018-12-31C$0.10 B107.89%
2017-12-31C$51.49 M-44.06%
2016-12-31C$92.06 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$23.52 M-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.58 B 21.13%๐Ÿ‡บ๐Ÿ‡ธ USA